Rajat Sood, MD
Gastroenterology · Henderson, NVNPI 1962504126
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $201,967 of the $257,598 with a category attached, or 78.4%. 40 manufacturers reported payments, led by Johnson & Johnson at 53.6% of the total. 2025 is the largest year on record at $88,333, 3.6 times the $24,583 reported in 2019. Among gastroenterology clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,026 payments — averaging $251.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$138K
- Gilead$106K
- Intra-sana Laboratories$4K
- AbbVie$3K
- Pfizer$896
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$834
- plus $5K from 34 others
What the payments were for
- Consulting fees$7,0503%
- Speaking & faculty fees$201,96778%
- Travel & lodging$30,80112%
- Food & beverage$16,9477%
- Education$4170%
- Gifts$4150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$257,598 in reported general payments places this provider in the 95th percentile of 103 gastroenterology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OcalivaObeticholic Acid | 12 | $113,952 |
| Dupixent PenDupilumab | 13 | $96,906 |
| Humira(Cf) PenAdalimumab | 12 | $85,564 |
| VemlidyTenofovir Alafenamide | 41 | $78,135 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 373 | $63,973 |
| XifaxanRifaximin | 14 | $45,081 |
| Ursodiol | 50 | $42,358 |
| Sucralfate | 112 | $7,021 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 39 | $6,237 |
| Pantoprazole Sodium | 670 | $6,135 |
| Mesalamine | 11 | $3,249 |
| CholestyramineCholestyramine (With Sugar) | 26 | $2,599 |
| Budesonide DrBudesonide | 11 | $2,326 |
| Tenofovir Disoproxil Fumarate | 17 | $1,820 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 78 | $1,218 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Intercept Pharmaceuticals, Inc.Ocaliva | $186 | $113,95212 claims |
| GileadVemlidy | $106,032 | $78,13541 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $364 | $63,973373 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $834 | $45,08114 claims |
| Braintree Laboratories, Inc.Sutab | $682 | $6,23739 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 103 gastroenterology providers in Nevada.
Other gastroenterology in Henderson
- Robert YehHenderson$16K
- Muthena MakladHenderson$10K
- Carmelo HerreroHenderson$9K
- Adedayo MokuoluHenderson$8K
- Jonathan RickerHenderson$8K
- Arumugam SivakumarHenderson$7K
- Bipin SaudHenderson$6K
- Christian StoneLas Vegas$1.1M
- Yasser SaloumNorth Las Vegas$49K
- James HanLas Vegas$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.